PTGS2 and colorectal cancer: In our study, Western blot showed that Rg3 reduces the expression of NF-κB-regulated gene products (cyclin D1, survivin, and COX2) in cancer cells, indicating that Rg3 enhances radiosensitivity of colorectal cancer.